Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 13, 2022
Total Value: $625M (95.5% shares, 4.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 750,000 | $339M | 54.2% | — | — | Put | 78462F103 |
| — | INARI MED INC | 220,000 | $19.94M | 3.2% | $91.64 | — | COM | 45332Y109 |
| — | MORPHIC HLDG INC | 465,654 | $18.7M | 3.0% | $50.29 | — | COM | 61775R105 |
| KURA | KURA ONCOLOGY INC | 924,147 | $14.86M | 2.4% | $23.45 | -38.4% | COM | 50127T109 |
| ASND | ASCENDIS PHARMA A/S | 120,000 | $14.08M | 2.3% | $117.36 | — | SPONSORED ADR | 04351P101 |
| — | SPRINGWORKS THERAPEUTICS INC | 247,000 | $13.94M | 2.2% | $63.44 | — | COM | 85205L107 |
| — | CHINOOK THERAPEUTICS INC | 845,155 | $13.83M | 2.2% | $16.27 | — | COM | 16961L106 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 174,500 | $11.76M | 1.9% | $63.96 | -8.6% | COM | G31249108 |
| — | TRAVERE THERAPEUTICS INC | 11,000,000 | $11.49M | 1.8% | $0.98 | — | NOTE 2.500% 9/1 | 761299AB2 |
| AZN | ASTRAZENECA PLC | 160,000 | $10.61M | 1.7% | $66.34 | — | SPONSORED ADR | 046353108 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 207,500 | $9.574M | 1.5% | $56.18 | -4.0% | COM | 98943L107 |
| — | SPRINGWORKS THERAPEUTICS INC | 160,000 | $9.03M | 1.4% | $63.44 | — | Put | 85205L107 |
| — | NANOSTRING TECHNOLOGIES INC | 7,000,000 | $7.753M | 1.2% | $1.11 | — | NOTE 2.625% 3/0 | 63009RAD1 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 75,000 | $7.359M | 1.2% | $82.45 | +2.3% | COM | 558868105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 300,000 | $7.104M | 1.1% | $30.94 | -8.9% | COM | 74366E102 |
| — | ARYA SCIENCES ACQUISITN CORP | 702,500 | $6.828M | 1.1% | $9.88 | — | CLASS A ORD SHS | G31658100 |
| — | REPARE THERAPEUTICS INC | 468,905 | $6.677M | 1.1% | $18.21 | — | COM | 760273102 |
| PMVP | PMV PHARMACEUTICALS INC | 317,400 | $6.608M | 1.1% | — | — | Call | 69353Y103 |
| LNTH | LANTHEUS HLDGS INC | 115,000 | $6.361M | 1.0% | $37.52 | 0.0% | COM | 516544103 |
| — | NANOSTRING TECHNOLOGIES INC | 171,592 | $5.963M | 1.0% | $34.75 | — | COM | 63009R109 |
| — | VINCERX PHARMA INC | 1,374,098 | $5.496M | 0.9% | $14.51 | — | COM NEW | 92731L106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 215,900 | $5.113M | 0.8% | $30.94 | -8.9% | Put | 74366E102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 300,000 | $4.758M | 0.8% | $25.78 | -33.0% | COM | 77313F106 |
| — | BRIDGEBIO PHARMA INC | 10,000,000 | $4.68M | 0.7% | $0.47 | — | NOTE 2.250% 2/0 | 10806XAD4 |
| — | BRIDGEBIO PHARMA INC | 7,500,000 | $4.38M | 0.7% | $0.74 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 125,000 | $4.258M | 0.7% | $33.71 | -5.2% | COM NEW | 15117B202 |
| — | BELLUS HEALTH INC NEW | 600,000 | $4.128M | 0.7% | $5.18 | — | COM NEW | 07987C204 |
| — | CYMABAY THERAPEUTICS INC | 1,272,244 | $3.957M | 0.6% | $3.35 | — | COM | 23257D103 |
| CRSP | CRISPR THERAPEUTICS AG | 55,000 | $3.452M | 0.6% | — | — | Call | H17182108 |
| — | HORIZON THERAPEUTICS PUB L | 30,000 | $3.156M | 0.5% | $105.20 | — | SHS | G46188101 |
| — | HEALTH SCIENCES ACQ CORP 2 | 300,000 | $2.973M | 0.5% | $12.02 | — | ORD SHS | G4411D109 |
| — | MEDICUS SCIENCES ACQUISITION | 300,000 | $2.934M | 0.5% | $9.65 | — | CL A SHS | G5960S108 |
| TVTX | TRAVERE THERAPEUTICS INC | 100,000 | $2.577M | 0.4% | $22.46 | +18.2% | COM | 89422G107 |
| — | CEREVEL THERAPEUTICS HLDNG I | 70,000 | $2.451M | 0.4% | $19.56 | — | COM | 15678U128 |
| XENE | XENON PHARMACEUTICALS INC | 80,000 | $2.446M | 0.4% | $25.73 | +16.4% | COM | 98420N105 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 559,019 | $2.426M | 0.4% | $10.24 | -59.9% | COM | 63909J108 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 70,000 | $2.425M | 0.4% | $34.64 | — | COM | 37890U108 |
| RLAY | RELAY THERAPEUTICS INC | 75,000 | $2.245M | 0.4% | — | — | Call | 75943R102 |
| LNTH | LANTHEUS HLDGS INC | 40,000 | $2.212M | 0.4% | $37.52 | 0.0% | Put | 516544103 |
| AUPH | AURINIA PHARMACEUTICALS INC | 175,000 | $2.167M | 0.3% | — | — | Call | 05156V102 |
| ACRS | ACLARIS THERAPEUTICS INC | 100,000 | $1.724M | 0.3% | $18.76 | -27.3% | COM | 00461U105 |
| BEAM | BEAM THERAPEUTICS INC | 30,000 | $1.719M | 0.3% | — | — | Call | 07373V105 |
| CNTX | CONTEXT THERAPEUTICS INC | 777,610 | $1.687M | 0.3% | $2.10 | 0.0% | COM | 21077P108 |
| — | CYCLACEL PHARMACEUTICALS INC | 400,000 | $1.22M | 0.2% | $7.22 | — | COM | 23254L603 |
| LIANY | LIANBIO | 325,000 | $1.206M | 0.2% | $4.26 | — | SPONSORED ADS | 53000N108 |
| — | SCIENCE 37 HOLDINGS INC | 221,382 | $1.184M | 0.2% | $10.18 | — | COM | 808644108 |
| — | KARUNA THERAPEUTICS INC | 7,500 | $951K | 0.2% | $126.80 | — | COM | 48576A100 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 50,000 | $925K | 0.1% | $19.21 | 0.0% | COM | 92790C104 |
| — | ATHERSYS INC NEW | 1,416,400 | $858K | 0.1% | — | — | Put | 04744L106 |
| — | RENOVACOR INC | 199,490 | $846K | 0.1% | $7.19 | — | COM | 75989E106 |
| — | CURIS INC | 350,000 | $833K | 0.1% | $7.79 | — | COM NEW | 231269200 |
| — | CELULARITY INC | 80,000 | $697K | 0.1% | — | — | Put | 151190105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 65,282 | $586K | 0.1% | $14.78 | — | SPONSORED ADS | 152309100 |
| — | CALITHERA BIOSCIENCES INC | 1,000,000 | $404K | 0.1% | $0.40 | — | COM | 13089P101 |
| — | IMMATICS N.V | 187,204 | $328K | 0.1% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| HYPR | HYPERFINE INC | 76,162 | $270K | 0.0% | $9.78 | -57.8% | COM CL A | 44916K106 |
| — | BLUEPRINT MEDICINES CORP | 1,988 | $127K | 0.0% | $63.88 | — | COM | 09627Y109 |
| — | RENOVACOR INC | 75,000 | $26,000 | 0.0% | $0.80 | — | *W EXP 99/99/999 | 75989E114 |
| — | MEDICUS SCIENCES ACQUISITION | 33,333 | $14,000 | 0.0% | $1.02 | — | *W EXP 02/12/202 | G5960S124 |